Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 2 study is to investigate whether intravenous administration of
REOLYSIN® therapeutic reovirus in combination with Paclitaxel and Carboplatin is effective
and safe in the treatment of squamous cell carcinoma of the head and neck.